Sodium-glucose cotransporter-2 inhibitors increase urinary tract infections?—a cross sectional analysis of a nationwide Japanese claims database
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a novel class of antidiabetic drugs. Guidelines for the proper use of SGLT2 inhibitors recommend caution regarding urinary tract infections (UTIs). However, little evidence has been reported on the relationship between SGLT2 inhibitors and UTIs i...
Saved in:
Main Authors: | Go Anan, Daisuke Kikuchi, Kenji Omae, Takuo Hirose, Kouji Okada, Takefumi Mori |
---|---|
Format: | Article |
Language: | English |
Published: |
The Japan Endocrine Society
2023-11-01
|
Series: | Endocrine Journal |
Subjects: | |
Online Access: | https://www.jstage.jst.go.jp/article/endocrj/70/11/70_EJ23-0317/_html/-char/en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Uninephrectomy and sodium‐glucose cotransporter 2 inhibitor administration delay the onset of hyperglycemia
by: Yuri Sakai Ishizaki, et al.
Published: (2024-11-01) -
Association of sodium–glucose cotransporter-2 inhibitors with mortality across the spectrum of myocardial infarction: a systematic review and meta-analysis
by: Michele Maremmani, et al.
Published: (2025-01-01) -
Sodium‐glucose cotransporter‐2 inhibitors in heart failure: an updated meta‐analysis
by: Yang Cao, et al.
Published: (2022-06-01) -
Health utility value of overactive bladder in Japanese older adults
by: Takashi Yoshioka, et al.
Published: (2025-01-01) -
Peroxiredoxin 5 Acts as a Negative Regulator of the Sodium-Chloride Cotransporter Involved in Alleviating Angiotensin II-Induced Hypertension
by: Hoon-In Choi, et al.
Published: (2025-01-01)